Literature DB >> 18217386

Medical implications of melatonin: receptor-mediated and receptor-independent actions.

R J Reiter1, D X Tan, L C Manchester, M Pilar Terron, L J Flores, S Koppisepi.   

Abstract

The functional versatility and diversity of melatonin has exceeded everyone's expectations. The evidence is substantial that melatonin has multiple receptor-mediated and receptor-independent actions. Considering the unexpectedly widespread distribution of cellular membrane receptors as well as the existence of nuclear binding sites/receptors and the fact that some of melatonin's actions are receptor-independent means that melatonin likely functions in every cell with which it comes in contact. This is highlighted by the fact that there are no morpho-physiological barriers to melatonin, e.g., the blood-brain barrier. In addition to its widespread actions, melatonin synthesis occurs in widely diverse tissues with its production not being relegated to the pineal gland. This should not be unexpected given that it is present throughout the animal kingdom including species that lack a pineal gland, e.g., insects, and in single cell organisms. In this review, only a few of melatonin's effects that involve the interaction of the indoleamine with receptors are described. These functions include the control of seasonal reproduction, modulation of sleep processes and influences on bone growth and osteoporosis. Among the actions of melatonin that are likely receptor independent and that are reviewed herein include its ability to neutralize free radicals which leads to a reduction in cataract formation, reducing oxidative stress due to exposure to hyperbaric hyperoxia, ameliorating hyperthyroidism and abating the toxicity of sepsis and septic shock. These actions alone speak to the diversity of beneficial effects of melatonin; however, the review is no way near exhaustive in terms of what melatonin is capable of doing. Because of its ubiquitous benefits, the pharmaceutical industry is developing melatonin analogues which interact with melatonin receptors. Clearly, the intent of the drugs is to take advantage of some of melatonin's numerous beneficial effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18217386

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  77 in total

Review 1.  Melatonin membrane receptors in peripheral tissues: distribution and functions.

Authors:  Radomir M Slominski; Russel J Reiter; Natalia Schlabritz-Loutsevitch; Rennolds S Ostrom; Andrzej T Slominski
Journal:  Mol Cell Endocrinol       Date:  2012-01-08       Impact factor: 4.102

Review 2.  Hepatoprotective actions of melatonin: possible mediation by melatonin receptors.

Authors:  Alexander M Mathes
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

3.  Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines.

Authors:  Lu-Lu Fan; Guo-Ping Sun; Wei Wei; Zhang-Gui Wang; Lei Ge; Wei-Zheng Fu; Hua Wang
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

4.  Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial.

Authors:  Egidio Del Fabbro; Rony Dev; David Hui; Lynn Palmer; Eduardo Bruera
Journal:  J Clin Oncol       Date:  2013-02-25       Impact factor: 44.544

5.  Tryptophan-enriched cereal intake improves nocturnal sleep, melatonin, serotonin, and total antioxidant capacity levels and mood in elderly humans.

Authors:  R Bravo; S Matito; J Cubero; S D Paredes; L Franco; M Rivero; A B Rodríguez; C Barriga
Journal:  Age (Dordr)       Date:  2012-05-24

Review 6.  Snapshot: implications for melatonin in endoplasmic reticulum homeostasis.

Authors:  Wei Hu; Zhiqiang Ma; Shouyin Di; Shuai Jiang; Yue Li; Chongxi Fan; Yang Yang; Dongjin Wang
Journal:  Br J Pharmacol       Date:  2016-11-16       Impact factor: 8.739

7.  Pancreatic stellate/myofibroblast cells express G-protein-coupled melatonin receptor 1.

Authors:  Sylvia Aust; Walter Jäger; Harald Kirschner; Martin Klimpfinger; Theresia Thalhammer
Journal:  Wien Med Wochenschr       Date:  2008

8.  The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors.

Authors:  Arabinda Das; Misty McDowell; Matthew J Pava; Joshua A Smith; Russel J Reiter; John J Woodward; Abhay K Varma; Swapan K Ray; Naren L Banik
Journal:  J Pineal Res       Date:  2010-01-17       Impact factor: 13.007

9.  Non-surgical periodontal therapy influences salivary melatonin levels.

Authors:  Kristina Bertl; Angelika Schoiber; Hady Haririan; Markus Laky; Irene Steiner; W D Rausch; Oleh Andrukhov; Xiaohui Rausch-Fan
Journal:  Clin Oral Investig       Date:  2012-07-31       Impact factor: 3.573

Review 10.  Good night and good luck: norepinephrine in sleep pharmacology.

Authors:  Heather A Mitchell; David Weinshenker
Journal:  Biochem Pharmacol       Date:  2009-10-13       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.